• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同念珠菌引起的念珠菌血症的临床表现和治疗:一项回顾性研究。

Clinical manifestations and treatment of candidemia caused by different Candida species: a retrospective study.

机构信息

Emergency Department, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, China.

Center of Infectious Disease, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, China.

出版信息

BMC Infect Dis. 2024 Nov 4;24(1):1234. doi: 10.1186/s12879-024-10128-2.

DOI:10.1186/s12879-024-10128-2
PMID:39497087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533373/
Abstract

OBJECTIVE

Candidemia leads to higher mortality and longer hospital-stay. While the studies about the clinical manifestations of candidemia caused by different Candida species and the relationship between the antifungal drugs and prognosis were rarely performed.

METHODS

This retrospective study enrolled all 94 patients diagnosed as candidemia from January 2020 to July 2023 in BTCH. Demographic information, comorbidities, laboratory parameters, medications and prognosis were collected and analyzed.

RESULTS

C. albicans was the most common specie of candidemia. There was no significant difference in age, gender and hospital-mortality in different species groups. Higher-level and longer duration of broad-spectrum antibiotic use, lower BMI, hypoalbuminemia, longer duration of PN and history of G coccemia were conclusive about mortality. The C.tropicalis group had higher SCRE levels (F = 8.40, P = 0.03) and shorter TTP (F = 5.03, P < 0.01) than other species. No distinction was found in different antifungal drugs groups including triazoles and echinocandins after 7 days treatment (χ = 0.05, P = 0.81). The efficacy was no difference between triazoles and echinocandins in the different species groups. (χ = 1.20, P = 0.75; χ = 0.05, P = 0.81).

CONCLUSION

C. albicans accounts the most among candida induecd candidemia.The C.tropicalis group had higher SCRE levels and shorter TTP than other groups. Elder, hypoproteinemia, lower BMI, longer duration and higher-level of broad-spectrum antibiotic use, longer PN support and G coccemia increase risks for candidemia. The efficacy of triazoles and echinocandins are the same when blood culture turned negative in 7 days.

摘要

目的

念珠菌血症可导致更高的死亡率和更长的住院时间。虽然有关于不同念珠菌引起的念珠菌血症的临床表现以及抗真菌药物与预后之间关系的研究很少进行。

方法

本回顾性研究纳入了 2020 年 1 月至 2023 年 7 月在我院确诊为念珠菌血症的 94 例患者。收集并分析了人口统计学信息、合并症、实验室参数、药物和预后。

结果

白色念珠菌是念珠菌血症最常见的菌种。不同菌种组在年龄、性别和院内死亡率方面无显著差异。广谱抗生素使用级别较高且时间较长、BMI 较低、低蛋白血症、PN 时间较长和 G 菌血症史与死亡率有关。C.tropicalis 组的 SCRE 水平较高(F=8.40,P=0.03),TTP 较短(F=5.03,P<0.01)。在不同的抗真菌药物治疗 7 天后,三唑类和棘白菌素类药物组之间没有区别(χ²=0.05,P=0.81)。不同菌种组中三唑类和棘白菌素类药物的疗效无差异(χ²=1.20,P=0.75;χ²=0.05,P=0.81)。

结论

白色念珠菌是念珠菌血症的主要病原菌。C.tropicalis 组的 SCRE 水平和 TTP 均短于其他组。年龄较大、低蛋白血症、BMI 较低、广谱抗生素使用时间较长、级别较高、PN 时间较长和 G 菌血症可增加念珠菌血症的风险。在 7 天内血培养转为阴性时,三唑类和棘白菌素类药物的疗效相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11533373/dcdebf0f278e/12879_2024_10128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11533373/dcdebf0f278e/12879_2024_10128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11533373/dcdebf0f278e/12879_2024_10128_Fig1_HTML.jpg

相似文献

1
Clinical manifestations and treatment of candidemia caused by different Candida species: a retrospective study.不同念珠菌引起的念珠菌血症的临床表现和治疗:一项回顾性研究。
BMC Infect Dis. 2024 Nov 4;24(1):1234. doi: 10.1186/s12879-024-10128-2.
2
Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.中国一家三级医院成人念珠菌血症:临床特征、菌种分布、耐药性和结局。
Mycopathologia. 2018 Aug;183(4):679-689. doi: 10.1007/s11046-018-0258-5. Epub 2018 Mar 23.
3
Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.引入广谱抗真菌药物后的突破性念珠菌血症:一项5年回顾性研究。
Med Mycol. 2018 Jun 1;56(4):406-415. doi: 10.1093/mmy/myx077.
4
Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.中国一家三级医院的医院获得性念珠菌血症的物种分布、抗真菌药敏性和死亡率的监测研究。
BMC Infect Dis. 2013 Jul 22;13:337. doi: 10.1186/1471-2334-13-337.
5
Candidemia in a Portuguese tertiary care hospital: Analysis of a 2-year period.葡萄牙一所三级保健医院的念珠菌血症:为期 2 年的分析。
J Mycol Med. 2019 Dec;29(4):320-324. doi: 10.1016/j.mycmed.2019.08.002. Epub 2019 Aug 14.
6
Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.危重症患者念珠菌血症的流行病学、物种分布、抗真菌药敏性和死亡危险因素:2011 年至 2017 年中国一家教学医院的回顾性研究。
Antimicrob Resist Infect Control. 2019 May 29;8:89. doi: 10.1186/s13756-019-0534-2. eCollection 2019.
7
Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.儿童中罕见念珠菌引起的念珠菌血症:新的威胁和对结局的影响。
Sci Rep. 2018 Oct 15;8(1):15239. doi: 10.1038/s41598-018-33662-x.
8
Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.2007-2014 年台湾地区一家医院不常见念珠菌引起的念珠菌血症的临床表现和分离株的抗真菌药敏性。
J Microbiol Immunol Infect. 2019 Aug;52(4):612-619. doi: 10.1016/j.jmii.2017.08.007. Epub 2017 Aug 26.
9
Impact on Antifungal Susceptibility Patterns of Previous vs. Revised Clinical and Laboratory Standards Institute Breakpoints for Candida Species Isolated from Candidemia: Experience of Two Tertiary Care Institutions in Japan.既往与修订后的临床和实验室标准协会念珠菌血症分离念珠菌属药敏试验折点对药敏模式的影响:日本两家三级医疗机构的经验
Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190110.
10
Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).伊朗南部设拉子市念珠菌血症的流行病学:一项前瞻性多中心研究(2016-2018 年)。
Med Mycol. 2021 May 4;59(5):422-430. doi: 10.1093/mmy/myaa059.

引用本文的文献

1
Epidemiological characteristics, antifungal susceptibility, and mortality factors of candidemia in adults at a tertiary teaching hospital in Zunyi, China (2016-2023).中国遵义某三级教学医院成人念珠菌血症的流行病学特征、抗真菌药敏性及死亡因素(2016 - 2023年)
BMC Infect Dis. 2025 May 21;25(1):726. doi: 10.1186/s12879-025-11021-2.
2
Pitt candidaemia score as an assessment tool for mortality in patients with candidaemia caused by and other species: a multicentre study conducted in Japan.皮特念珠菌血症评分作为评估由白色念珠菌和其他念珠菌属引起的念珠菌血症患者死亡率的工具:一项在日本开展的多中心研究。
JAC Antimicrob Resist. 2025 May 20;7(3):dlaf078. doi: 10.1093/jacamr/dlaf078. eCollection 2025 Jun.

本文引用的文献

1
Emerging trends in pediatric candidemia: mapping the rise in Candida parapsilosis incidence and antifungal resistance in Turkey.儿科念珠菌血症的新趋势:土耳其近平滑念珠菌发病率和抗真菌药物耐药性的上升趋势。
J Trop Pediatr. 2024 Aug 10;70(5). doi: 10.1093/tropej/fmae015.
2
Virulence and resistance factors of Nakaseomyces glabratus (formerly known as Candida glabrata) in Europe: A systematic review.欧洲光滑念珠菌(原称光滑假丝酵母菌)的毒力和耐药因子:一项系统综述
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):377-388. doi: 10.1111/jdv.20273. Epub 2024 Aug 13.
3
Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China.
念珠菌血症的流行病学及危险因素:来自中国一家教学医院的8年回顾性研究
Infect Drug Resist. 2024 Aug 7;17:3415-3423. doi: 10.2147/IDR.S471171. eCollection 2024.
4
Clinical characteristics and outcomes of patients with candidemia during the COVID-19 pandemic: Insights from experience in the Omicron era.COVID-19 大流行期间念珠菌血症患者的临床特征和结局:奥密克戎时代的经验洞察。
J Microbiol Immunol Infect. 2024 Oct;57(5):812-821. doi: 10.1016/j.jmii.2024.07.014. Epub 2024 Aug 3.
5
Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019-2021).伊朗东北部马什哈德念珠菌血症的流行病学:一项前瞻性多中心研究(2019 - 2021年)
J Fungi (Basel). 2024 Jul 12;10(7):481. doi: 10.3390/jof10070481.
6
Predominance of in candidemia among patients with solid tumor cancer in Oman: A retrospective study.阿曼实体肿瘤癌症患者念珠菌血症中 的优势:一项回顾性研究。 (你提供的原文中“Predominance of ”这里有缺失内容哦。)
IJID Reg. 2024 Jun 15;12:100389. doi: 10.1016/j.ijregi.2024.100389. eCollection 2024 Sep.
7
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.念珠菌血症的归因死亡率——欧洲临床微生物与感染性疾病学会念珠菌III期多国欧洲观察性队列研究结果
J Infect. 2024 Sep;89(3):106229. doi: 10.1016/j.jinf.2024.106229. Epub 2024 Jul 16.
8
Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list.近平滑念珠菌:一项旨在为世界卫生组织真菌优先病原体清单提供信息的系统评价。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad131.
9
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county.影响念珠菌血症结局的因素:一项在瑞典某县进行的回顾性研究。
Mycoses. 2024 Jul;67(7):e13758. doi: 10.1111/myc.13758.
10
The Diagnostic Accuracy of Procalcitonin and Its Combination with Other Biomarkers for Candidemia in Critically Ill Patients.降钙素原及其与其他生物标志物联合检测对危重症患者念珠菌血症的诊断准确性
J Clin Med. 2024 Jun 18;13(12):3557. doi: 10.3390/jcm13123557.